The toll‐like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome
Open Access
- 5 March 2004
- journal article
- concise communications
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (3) , 999-1001
- https://doi.org/10.1002/art.20114
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptorsCellular Microbiology, 2007
- Salmonella septicemia in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Association with decreased interferon‐γ production and toll‐like receptor 4 expressionArthritis & Rheumatism, 2003
- Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide SignallingThe Journal of Experimental Medicine, 2003
- Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4The Journal of Experimental Medicine, 2002
- The Extra Domain A of Fibronectin Activates Toll-like Receptor 4Journal of Biological Chemistry, 2001
- Natural adjuvants: Endogenous activators of dendritic cellsNature Medicine, 1999
- Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?Arthritis & Rheumatism, 1997
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980